Synergistic antitumor activity of vitamins C and K3 on human urologic tumor cell lines
- 20 September 1996
- journal article
- Published by Elsevier in Life Sciences
- Vol. 59 (17), 1389-1400
- https://doi.org/10.1016/0024-3205(96)00466-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- A1-Receptor-mediated effect of adenosine on the release of acetylcholine from the myenteric plexus: Role and localization of ecto-ATPase and 5′-nucleotidaseNeuroscience, 1995
- Comparison of antitumor activity of vitamins K1, K2 and K3 on human tumor cells by two (MTT and SRB) cell viability assaysLife Sciences, 1993
- Management of relapsing disease in prostate cancerCancer, 1992
- Menadione: Spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell linesBiochemical Pharmacology, 1991
- Bladder cancer.Advances in laboratory innovations and clinical management, with emphasis on innovations allowing bladder-sparing approaches for patients with invasive tumorsCancer, 1990
- Evaluation of synergism or antagonism for the combined action of antiviral agentsAntiviral Research, 1990
- Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 actionCancer, 1989
- Antimetabolic activity of l-ascorbic acid in human and animal tumorsInternational Journal of Biochemistry, 1989
- Non‐toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre‐treatmentInternational Journal of Cancer, 1987